“You can’t afford to fail, to have your hypothesis disproven,” Dr. Fang said. “It’s a small minority of scientists who engage in frank misconduct. It’s a much more insidious thing that you feel compelled to put the best face on everything.”For these kinds to concerns override scientific values (and they do heavily override them, at least in some fields of biomedical research), is of course a serious ethical failure, but a deeper problem is that it's corrosive to the morale and career prospects of the researchers who actually give a shit about the scientific and medical challenges they're studying.
During a decade as head of global cancer research at Amgen, C. Glenn Begley identified 53 "landmark" publications -- papers in top journals, from reputable labs -- for his team to reproduce. Begley sought to double-check the findings before trying to build on them for drug development.Fraudulent publication really does undermine public trust in science, it really does get noticed, and it really does kill people.
Result: 47 of the 53 could not be replicated. He described his findings in a commentary piece published on Wednesday in the journal Nature.
"It was shocking," said Begley, now senior vice president of privately held biotechnology company TetraLogic, which develops cancer drugs. "These are the studies the pharmaceutical industry relies on to identify new targets for drug development. But if you're going to place a $1 million or $2 million or $5 million bet on an observation, you need to be sure it's true. As we tried to reproduce these papers we became convinced you can't take anything at face value."
The failure to win "the war on cancer" has been blamed on many factors, from the use of mouse models that are irrelevant to human cancers to risk-averse funding agencies. But recently a new culprit has emerged: too many basic scientific discoveries, done in animals or cells growing in lab dishes and meant to show the way to a new drug, are wrong.
Everything about that statement is wrong. ... Fraudulent publication really does undermine public trust in science, it really does get noticed, and it really does kill people.Except I was talking about fradulent publication outside of the field of drug research
This seems to be a problem that is affecting one particular field: Drug research in biology. That's probably one of the most directly-mobilizable areas in science: You develop a drug, you get a patent, and then you make your money.Then when someone pointed out there are problems in other fields, I said those problems don't have an impact on the public trust in science, whereas biology and drug research do. And your example was exactly the kind of thing I was saying did undermine public confidence.
« Older Tchaikovsky Timelapse manually snapped frames in-b... | The Nine Circles Of Hell, As D... Newer »
This thread has been archived and is closed to new comments
posted by daniel_charms at 7:05 AM on May 13, 2012 [1 favorite]